-
Hello World!
From Molecules to Meaning: Launching My Research and Writing Journey
Welcome to my website.
I am a Ph.D. candidate in organic chemistry working at the interface of synthetic chemistry, drug design, and targeted delivery systems. This platform is intended to serve as a structured space where I share my research, ideas, and broader intellectual interests.
My research focuses on the design and synthesis of small-molecule therapeutics, with particular emphasis on prodrug strategies, self-immolative linkers, and controlled-release systems. These approaches aim to address fundamental challenges in drug development, including poor pharmacokinetics, lack of selectivity, and systemic toxicity. Current projects include the development of aquaporin-4 inhibitors for cardiac injury, phosphate-based bioconjugation strategies, and controlled-release prodrugs of mycophenolic acid for immunomodulation.
Beyond experimental work, I am interested in the underlying logic of molecular design—how structure governs reactivity and how reactivity can be engineered into function. This perspective drives both my scientific approach and my long-term goal of contributing to translational research in pharmaceutical development.
In parallel with my research, I actively engage in creative writing, including poetry, short stories, and long-form narratives. Writing provides a complementary framework for thinking—one that emphasizes clarity, structure, and the ability to communicate complex ideas effectively. I see scientific and creative work not as separate domains but as interconnected processes that reinforce analytical thinking and expression.
This website will evolve over time and will include:
- Research summaries and project updates
- Mechanistic insights and synthetic strategies
- Perspectives on medicinal chemistry and drug delivery
- Selected creative writing pieces
The objective is straightforward: to document my work, share knowledge, and build a coherent professional identity at the intersection of chemistry and communication.
If you are interested in research collaboration, academic discussion, or opportunities in pharmaceutical science, I welcome you to connect.
—
Akhil Sarkar
